Multiscale Cancer Modeling - Deisboeck, Thomas S.; Stamatakos, Georgios; (szerk.) - Prospero Internetes Könyváruház

Multiscale Cancer Modeling

 
Kiadás sorszáma: 1
Kiadó: CRC Press
Megjelenés dátuma:
 
Normál ár:

Kiadói listaár:
GBP 45.99
Becsült forint ár:
23 516 Ft (22 397 Ft + 5% áfa)
Miért becsült?
 
Az Ön ára:

18 813 (17 918 Ft + 5% áfa )
Kedvezmény(ek): 20% (kb. 4 703 Ft)
A kedvezmény érvényes eddig: 2024. december 31.
A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
Kattintson ide a feliratkozáshoz
 
Beszerezhetőség:

Becsült beszerzési idő: A Prosperónál jelenleg nincsen raktáron, de a kiadónál igen. Beszerzés kb. 2-3 hét..
A Prosperónál jelenleg nincsen raktáron.
Nem tudnak pontosabbat?
 
  példányt

 
Rövid leírás:

With contributions from some of the top in silico modeling groups in the United States and Europe, Multiscale Cancer Modeling discusses the scientific and technical expertise necessary to conduct innovative cancer modeling research across scales. It presents modeling methods and results at the forefront of cancer simula

Hosszú leírás:

Cancer is a complex disease process that spans multiple scales in space and time. Driven by cutting-edge mathematical and computational techniques, in silico biology provides powerful tools to investigate the mechanistic relationships of genes, cells, and tissues. It enables the creation of experimentally testable hypotheses, the integration of data across scales, and the prediction of tumor progression and treatment outcome (in silico oncology).

Drawing on an interdisciplinary group of distinguished international experts, Multiscale Cancer Modeling discusses the scientific and technical expertise necessary to conduct innovative cancer modeling research across scales. It presents contributions from some of the top in silico modeling groups in the United States and Europe.

The ultimate goal of multiscale modeling and simulation approaches is their use in clinical practice, such as supporting patient-specific treatment optimization. This volume covers state-of-the-art methods of multiscale cancer modeling and addresses the field?s potential as well as future challenges. It encourages collaborations among researchers in various disciplines to achieve breakthroughs in cancer modeling.



"This volume covers state-of-the-art methods of multiscale cancer modeling and addresses the field's potential as well as future challenges ? It presents contributions from some of the top in silico modeling groups in the United States and Europe."
?Zentralblatt MATH

Tartalomjegyzék:

Evolution, Regulation and Disruption of Homeostasis and Its Role in Carcinogenesis. Cancer Cell: Linking Oncogenic Signaling to Molecular Structure. Has Cancer Sculpted the Genome? Modeling Linkage and the Role of Tetraploidy in Neoplastic Progression. Catastrophes and Complex Networks in Genomically Unstable Tumorigenesis. A Stochastic Multiscale Model Framework for Intestinal Stem Cell Homeostasis. Multiscale Modeling of Colonic Crypts and Early Colorectal Cancer. The Physical Microenvironment in Somatic Evolution of Cancer. Multiscale Modeling of Cell Motion in Three-Dimensional Environments. Simulating Cancer Growth with Agent-Based Models. Diffusional Instability as a Mechanism of Tumor Invasion. Continuum Models of Mesenchymal Cell Migration and Sprouting Angiogenesis. Do Tumor Invasion Strategies Follow Basic Physical Laws?. Multiscale Mathematical Modeling of Vascular Tumor Growth: An Exercise in Transatlantic Cooperation. A Multiscale Simulation Framework for Modeling Solid Tumor Growth with an Explicit Vessel Network. Building Stochastic Models for Cancer Growth and Treatment. Bridging from Multiscale Modeling to Practical Clinical Applications in the Study of Human Gliomas. Personalization of Reaction-Diffusion Tumor Growth Models in MR Images: Application to Brain Gliomas Characterization and Radiotherapy Planning. In Silico Oncology Part I: Clinically Oriented Cancer Multilevel Modeling Based on Discrete Event Simulation. In Silico Oncology Part II: Clinical Requirements.